Literature DB >> 34351669

H syndrome: A review of treatment options and a hypothesis of phenotypic variability.

Hagar Nofal1, Rania AlAkad1, Ahmad Nofal1, Eman Rabie2,3, Thithiwat Chaikul4, Frank Po-Chao Chiu4, Rashida Pramanik4, Ahmad Alabdulkareem4, Alexandros Onoufriadis4.   

Abstract

H syndrome is a rare autosomal recessive disorder with clinical features comprising: Hyperpigmentation, Hypertrichosis, Hearing loss, Heart anomalies, low Height, Hypogonadism and Hepatosplenomegaly. H syndrome results from loss-of-function mutations in SLC29A3 which leads to abnormal proliferation and function of histiocytes. Herein, we discuss the considerable phenotypic heterogeneity detected in a consanguineous Egyptian family comprising of 4 affected siblings, two of which are monozygotic twin and the possible therapeutics. The phenotypic variability may be attributed to the role of histiocytes in the tissue response to injury. Such variable expressivity of H syndrome renders the diagnosis challenging and delays the management. The different treatment approaches used for this rare entity are reviewed. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  H syndrome; Histiocytosis; SLC29A3; hyperpigmentation; hypertrichosis; sclerosis

Year:  2021        PMID: 34351669     DOI: 10.1111/dth.15082

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  1 in total

Review 1.  Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29).

Authors:  Marçal Pastor-Anglada; Aida Mata-Ventosa; Sandra Pérez-Torras
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.